Evolent Health

Value-Based Care News and Insights

loadinggo down
Evolent Health logo
  • All Resources
    • All Resources
  • Browse by Topic
    • Browse by Topic
    • Accountable Care Organizations
    • Core Administration
    • COVID-19
    • Data Science
    • Medicaid
    • Medicare
    • Physician Engagement
    • Pharmacy Benefit Management
    • Population Health & Care Mgmt.
    • Risk Adjustment
    • Social Determinants of Health
    • Value-Based Payment
×
Knowledge Center » Wistia - Low Value Regimens » A Review of Lurbinectedin and Topotecan
× Share this Video
  • Facebook
  • Twitter
  • Work Email
  • LinkedIn

A Review of Lurbinectedin and Topotecan

August 17, 2023
  • Share this Video
  • Facebook
  • Twitter
  • Work Email
  • LinkedIn
Return to Home
 
× Streams
  • All Resources
  • Browse by Topic
    • Accountable Care Organizations
    • Core Administration
    • COVID-19
    • Data Science
    • Medicaid
    • Medicare
    • Physician Engagement
    • Pharmacy Benefit Management
    • Population Health & Care Mgmt.
    • Risk Adjustment
    • Social Determinants of Health
    • Value-Based Payment
loading
  • Share this Hub
  • Facebook
  • Twitter
  • Work Email
  • LinkedIn
×